BAT4706 / Bio-Thera Solutions - LARVOL DELTA

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients (clinicaltrials.gov) - P1 | N=210 | Recruiting | Sponsor: Bio-Thera Solutions | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Oncology • Solid Tumor

Biotech: BAT7104 injection combined with BAT4706 injection for the treatment of advanced malignant tumors received drug clinical trial approval notice [Google translation] (STCN) - "...Biotech (688177) announced on the evening of January 11 that the company recently received a drug clinical trial approval notice approved and issued by the State Food and Drug Administration. The company’s drug under development, BAT7104 injection, is combined with BAT4706 injection. Clinical trial application for advanced malignancy approved."

New trial • Oncology

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients (clinicaltrials.gov) - P1 | N=210 | Not yet recruiting | Sponsor: Bio-Thera Solutions

Metastases • Trial completion date • Trial initiation date • Trial primary completion date • Oncology • Solid Tumor

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients (clinicaltrials.gov) - P1 | N=210 | Not yet recruiting | Sponsor: Bio-Thera Solutions

Metastases • New P1 trial • Oncology • Solid Tumor

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=64 | Recruiting | Sponsor: Bio-Thera Solutions | Trial completion date: Jan 2023 ➔ Dec 2024 | Trial primary completion date: Sep 2022 ➔ Dec 2024

Metastases • Trial completion date • Trial primary completion date • Melanoma • Oncology • Solid Tumor

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors (clinicaltrials.gov) - P1; N=64; Recruiting; Sponsor: Bio-Thera Solutions

Clinical • New P1 trial • Melanoma • Oncology • Solid Tumor